Deutsch English Français

Contact

EP1009846

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1009846

EP1009846 - ALPHAVIRUS-DERIVED VECTORS USEFUL AS VACCINES PROVIDING PROTECTION AGAINST PARAMYXOVIRUS INFECTION [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 07.03.2008 Database last updated on 16.07.2024
Most recent event Tooltip	08.01.2010	Lapse of the patent in a contracting state New state(s): CY, LU	published on 10.02.2010 [2010/06]
Applicant(s)	For all designated states Sanofi Pasteur Limited 1755 Steeles Avenue West Toronto, ON M2R 3T4 / CA
	[N/P]
Former [2007/18]	For all designated states Sanofi Pasteur Limited 1755 Steeles Avenue West Toronto, Ontario M2R 3T4 / CA
Former [2001/21]	For all designated states Aventis Pasteur Limited 1755 Steeles Avenue West Toronto, Ontario M2R 3T4 / CA
Former [2000/25]	For all designated states CONNAUGHT LABORATORIES LIMITED 1755 Steeles Avenue West North York Ontario M2R 3T4 / CA
Inventor(s)	01 / PARRINGTON, Mark 45 Martin Street Bradford, Ontario L3Z 1Z4 / CA
	[2000/25]
Representative(s)	Bizley, Richard Edward, et al Avidity IP Broers Building Hauser Forum 21 J J Thomson Ave Cambridge CB3 0FA / GB
	[N/P]
Former [2000/25]	Bizley, Richard Edward, et al Hepworth, Lawrence, Bryer & Bizley Merlin House Falconry Court Baker's Lane Epping Essex CM16 5DQ / GB
Application number, filing date	98942413.0	03.09.1998
	[2000/25]
	WO1998CA00840
Priority number, date	US19970923558	04.09.1997 Original published format: US 923558
	[2000/25]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9911808
	Date:	11.03.1999
	Language:	EN
	[1999/10]
	Type:	A1 Application with search report
	No.:	EP1009846
	Date:	21.06.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 11.03.1999 takes the place of the publication of the European patent application.
	[2000/25]
	Type:	B1 Patent specification
	No.:	EP1009846
	Date:	02.05.2007
	Language:	EN
	[2007/18]
Search report(s)	International search report - published on:	EP	11.03.1999
Classification	IPC:	C12N15/86, C12N15/45, C07K14/115, C07K14/135, A61K31/70	[2000/25]
	CPC:	C07K14/005 (EP,US); A61P31/12 (EP); A61P31/14 (EP); A61K2039/51 (EP,US); C12N2760/18522 (EP,US); C12N2770/36143 (EP,US); (+) C12N2830/002 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/25]
Extension states	AL	28.03.2000
	LT	28.03.2000
	LV	28.03.2000
	MK	28.03.2000
	RO	28.03.2000
	SI	28.03.2000
Title	German:	VON ALPHAVIRUS ABGELEITETE VEKTOREN ALS IMPFSTOFFE GEGEN EINE PARAMYXOVIRUSINFEKTION	[2000/25]
	English:	ALPHAVIRUS-DERIVED VECTORS USEFUL AS VACCINES PROVIDING PROTECTION AGAINST PARAMYXOVIRUS INFECTION	[2000/25]
	French:	VECTEURS A BASE D'ALPHAVIRUS POUR DES VACCINS A ARN CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL	[2006/44]
	Former [2000/25]	VACCINS A ARN CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL
Entry into regional phase	28.03.2000	National basic fee paid
	28.03.2000	Designation fee(s) paid
	28.03.2000	Examination fee paid
Examination procedure	30.03.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	28.03.2000	Examination requested [2000/25]
	23.10.2003	Despatch of a communication from the examining division (Time limit: M06)
	10.06.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	09.07.2004	Reply to a communication from the examining division
	21.11.2005	Despatch of a communication from the examining division (Time limit: M06)
	24.04.2006	Reply to a communication from the examining division
	19.05.2006	Despatch of a communication from the examining division (Time limit: M02)
	19.07.2006	Reply to a communication from the examining division
	28.11.2006	Communication of intention to grant the patent
	20.03.2007	Fee for grant paid
	20.03.2007	Fee for publishing/printing paid
Opposition(s)	05.02.2008	No opposition filed within time limit [2008/15]
Request for further processing for:	09.07.2004	Request for further processing filed
	09.07.2004	Full payment received (date of receipt of payment) Request granted
	22.07.2004	Decision despatched
Fees paid	Renewal fee
	20.09.2000	Renewal fee patent year 03
	21.09.2001	Renewal fee patent year 04
	23.09.2002	Renewal fee patent year 05
	24.09.2003	Renewal fee patent year 06
	23.09.2004	Renewal fee patent year 07
	27.09.2005	Renewal fee patent year 08
	14.09.2006	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	02.05.2007
	CH	02.05.2007
	CY	02.05.2007
	DK	02.05.2007
	FI	02.05.2007
	LI	02.05.2007
	NL	02.05.2007
	SE	02.08.2007
	GR	03.08.2007
	ES	13.08.2007
	IE	03.09.2007
	LU	03.09.2007
	MC	30.09.2007
	PT	02.10.2007
	[2010/06]
Former [2008/45]	AT	02.05.2007
	CH	02.05.2007
	DK	02.05.2007
	FI	02.05.2007
	LI	02.05.2007
	NL	02.05.2007
	SE	02.08.2007
	GR	03.08.2007
	ES	13.08.2007
	IE	03.09.2007
	MC	30.09.2007
	PT	02.10.2007
Former [2008/22]	AT	02.05.2007
	CH	02.05.2007
	DK	02.05.2007
	FI	02.05.2007
	LI	02.05.2007
	NL	02.05.2007
	SE	02.08.2007
	GR	03.08.2007
	ES	13.08.2007
	MC	30.09.2007
	PT	02.10.2007
Former [2008/21]	AT	02.05.2007
	CH	02.05.2007
	DK	02.05.2007
	FI	02.05.2007
	LI	02.05.2007
	NL	02.05.2007
	SE	02.08.2007
	GR	03.08.2007
	ES	13.08.2007
	PT	02.10.2007
Former [2008/16]	AT	02.05.2007
	CH	02.05.2007
	DK	02.05.2007
	FI	02.05.2007
	LI	02.05.2007
	NL	02.05.2007
	SE	02.08.2007
	ES	13.08.2007
	PT	02.10.2007
Cited in	International search	[A]WO9617072 (VIAGENE INC [US]) [A] 1-53 * see the whole document, especially page 38, lines 20-31 and page 61 lines 12-32 *;
		[YD]WO9640945 (CONNAUGHT LAB [CA], et al) [YD] 1-53 * column W *;
		[A]US5614372 (LILJA HANS [SE], et al) [A] 1-53 * column 5, line 61 - line 65 *;
		[DY] - LILJESTROEM P. ET AL., "A NEW GENERATION OF ANIMAL CELL EXPRESSION VECTORS BASED ON THE SEMLIKI FOREST VIRUS REPLICON", BIO/TECHNOLOGY, (199112), vol. 9, pages 1356 - 1361, XP000616021 [DY] 1-53 * column W * DOI: http://dx.doi.org/10.1038/nbt1291-1356
		[A] - SCHLESINGER S., "ALPHAVIRUSES - VECTORS FOR THE EXPRESSION OF HETEROLOGOUS GENES", TRENDS IN BIOTECHNOLOGY, (19930101), vol. 11, no. 1, pages 18 - 22, XP000358625 [A] 1-53 * page 20, column L, paragraph L - column R, paragraph 1 * DOI: http://dx.doi.org/10.1016/0167-7799(93)90070-P
		[DA] - ZHOU X. ET AL., "Self-replicating Semliki-Forest virus RNA as recombinant vaccine.", VACCINE, (1994), vol. 12, no. 16, pages 1510 - 1514, XP002089524 [DA] 1-53 * column W * DOI: http://dx.doi.org/10.1016/0264-410X(94)90074-4

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p